Home

We are looking forward to seeing you for our 37th annual conference December 11th–13th, 2025. New for this year, we are able to offer the course recordings, including CME credits for up to 90 days after the course ends.

Overview

This course provides the active, intermediate-to-advanced clinician with a comprehensive review of the science of HIV and key infections including HCV, HBV, RSV, H5N1 and COVID, as well as an update on the application of appropriate therapies. Safe and effective use of antiretroviral therapy for both prevention of HIV and treatment of HIV is an indispensable foundational skill which this course emphasizes. Available and emerging ART strategies will be reviewed in depth, including new long-acting injectables and oral formulations. Providing successful care for people living with HIV/AIDS in 2025 also involves understanding and treating myriad co-morbid conditions in the fields of cardiology, gastroenterology, endocrinology, dermatology, neurology, behavioral medicine, and addiction medicine. Close collaboration with other specialists and diverse teams of health professionals is vital for the best care of our complex patients. All course lecturers are leading clinicians and/or researchers who are dedicated to teaching in their areas of expertise. All course lecturers are leading clinicians and/or researchers who are dedicated to teaching in their areas of expertise.

For ambitious new clinicians who want a challenge, we still offer our New Clinicians Track (NCT). This track provides five additional lectures that cover antiretroviral therapy (ART) 101, basic HIV pharmacology, management of ART resistance, IRIS, and opportunistic infections.

All lectures will be cased-based with multiple audience response system (ARS) questions per session. Question and answer time as well as faculty panels are woven into each conference day. These interdisciplinary faculty panels are designed with extra ARS questions and allow you to privately test your individual knowledge against our experts throughout the conference. Questions that arise in the Chat will be answered each day by our dedicated faculty. The syllabus will be available for a year and recordings of the conference available for 90 days.

Included in your registration fee is access to the course recordings on demand after the conference ends for an Additional 90 days and CME credit can be obtained for up to 90 days.

Onsite and Remote Learning Options:
The course will be offered as a hybrid conference. Registrants have the option to attend in person or to tune in remotely via zoom live stream during programming hours (Pacific Time). Login instructions along with the digital syllabus will be shared with attendees before the meeting. Included in your registration fee is access to the course recordings on demand after the conference and for and additional 90 days and CME credit can be obtained for up to 90 days. 
**Fully Virtual on December 13, 2025 for all attendees** 

Objectives

An attendee completing this course will be able to improve skills and strategies to:

• Diagnose, treat, and prevent important conditions in HIV medicine and HIV medicine subspecialties, for improved patient outcomes;
• Apply in practice the latest treatment guidelines and recommendations for the prevention of HIV transmission and the appropriate use of PEP, PrEP and DoxyPEP including the use of long-acting options;
• Apply new recommendations for initiating and timely switching of antiretroviral combinations including long-acting ART in appropriate patients;
• Identify new developments and apply treatment recommendations in HIV related, dermatologic, metabolic, cardiovascular, and addiction medicine;
• Diagnose and apply new recommendations for the treatment of HBV, HCV, cirrhosis, MASH and MASLD;
• Align practice patterns more with current evidence and guidelines for treating STI’s and HIV;
• Apply in practice the latest transmission prevention guidelines for COVID, Influenza, and RSV as well as the updated treatment guidelines for COVID, Influenza and RSV;
• Apply new recommendations for appropriate treatment of acute COVID-19 and Long COVID